Colin B O'Leary

Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies

M. Dhodapkar, R. Ahmed, M. Suthar, 2023, Blood Advances.

Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study.

Pamela Blair Allen, M. Lechowicz, J. Switchenko, 2023, Clinical lymphoma, myeloma & leukemia.

CLL-515 Antibody Responses Against SARS-CoV-2 Variants after Booster Vaccination in Patients With B Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

R. Ahmed, A. Nooka, K. Blum, 2022, Clinical Lymphoma Myeloma and Leukemia.

Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies

M. Dhodapkar, J. Wrammert, R. Ahmed, 2022, Cancer research communications.

Humoral Responses Against SARS-CoV-2 and Variants of Concern After mRNA Vaccines in Patients With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

M. Dhodapkar, R. Ahmed, A. Nooka, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Presentation and Outcome Differences Between Black Patients and Patients of Other Races and Ethnicities With Mycosis Fungoides and Sézary Syndrome.

Pamela Blair Allen, M. Lechowicz, Mohammad K. Khan, 2022, JAMA dermatology.